A protein-blocking drug extended life by 25% in mice. Could it work in humans?
Briefly

Inhibiting IL-11 in mice extended lifespan by up to 25% and improved metabolism, muscle function, and frailty. The study suggests a potential avenue for human longevity.
Researchers propose anti-IL-11 therapy could extend human healthspan and lifespan. Early human trials targeting IL-11 in fibrotic lung disease hint at its translatability to human health.
Read at Fortune Well
[
]
[
|
]